BIOCON
Back to Cashflow Statement
|
BIOCON Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,994 Cr | ₹4,061 Cr | ₹2,954 Cr | ₹1,853 Cr | ₹1,177 Cr |
What is the latest Cash Flow from Operating Activities ratio of BIOCON ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,994 Cr |
| Mar2025 | ₹4,061 Cr |
| Mar2024 | ₹2,954 Cr |
| Mar2023 | ₹1,853 Cr |
| Mar2022 | ₹1,177 Cr |
How is Cash Flow from Operating Activities of BIOCON Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,994 Cr | -50.90 | |
| Mar2025 | ₹4,061 Cr | 37.49 | |
| Mar2024 | ₹2,954 Cr | 59.45 | |
| Mar2023 | ₹1,853 Cr | 57.45 | |
| Mar2022 | ₹1,177 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹70,077.1 Cr | 1.7% | 6.5% | 11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 1.7% |
6.5% |
11.9% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses